2022
DOI: 10.1038/s41420-022-00927-4
|View full text |Cite
|
Sign up to set email alerts
|

Regulation of the Tec family of non-receptor tyrosine kinases in cardiovascular disease

Abstract: Tyrosine phosphorylation by protein tyrosine kinases (PTKs) is a type of post-translational modification. Tec kinases, which are a subfamily of non-receptor PTKs, were originally discovered in the hematopoietic system and include five members: Tec, Btk, Itk/Emt/Tsk, Etk/Bmx, and Txk/Rlk. With the progression of modern research, certain members of the Tec family of kinases have been found to be expressed outside the hematopoietic system and are involved in the development and progression of a variety of disease… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
18
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 17 publications
(18 citation statements)
references
References 97 publications
0
18
0
Order By: Relevance
“…Changes in the expression of fucosylated oligosaccharides have been observed in pathological processes such as atherosclerosis [ 149 ]. In addition, the phosphorylation modification of tyrosine is related to the formation of esters, which may also be involved in lipid metabolism and the occurrence and progression of diseases [ 150 ].…”
Section: Resultsmentioning
confidence: 99%
“…Changes in the expression of fucosylated oligosaccharides have been observed in pathological processes such as atherosclerosis [ 149 ]. In addition, the phosphorylation modification of tyrosine is related to the formation of esters, which may also be involved in lipid metabolism and the occurrence and progression of diseases [ 150 ].…”
Section: Resultsmentioning
confidence: 99%
“…BTK belongs to a sub-family of non-receptor protein tyrosine kinases (TEC kinases) and plays an essential role in the proliferation, differentiation, and survival of B cells. BTK also plays a role in the function of innate cells and T cells and mediates Toll-like receptor signaling and NLRP3 inflammasome activation 1 . BTKis have revolutionized landscape therapy of B cell malignancies such as chronic lymphocytic leukemia, diffuse large B-cell lymphoma, mantle cell lymphoma, and Waldenstrom macroglobulinemia.…”
Section: Discussionmentioning
confidence: 99%
“… 49 According to whether PTK is a cell membrane receptor, PTKs can be divided into nonreceptor type and membrane receptor type. 50 Receptor‐type tyrosine kinases include EGFR, VEGFR, and FGFR. Abnormal activation of these kinases is related to angiogenesis, tumor invasion, and metastasis.…”
Section: Phosphorylationmentioning
confidence: 99%